Stifel Downgrades Surgery Partners (SGRY) to Sell

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Stifel Downgrades Surgery Partners (SGRY) to Sell

Surgery Partners (SGRY) PT Lowered to $17 at Citi

August 11, 2017 8:42 AM EDT

Citi lowered its price target on Surgery Partners (NASDAQ: SGRY) to $17.00 (from $28.00) while maintaining a Buy rating.

... More

Raymond James Downgrades Surgery Partners (SGRY) to Market Perform

August 9, 2017 3:52 AM EDT

Raymond James downgraded Surgery Partners (NASDAQ: SGRY) from Strong Buy to Market Perform.

For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.

Shares of Surgery Partners closed at $19.15 yesterday.

... More

KeyBanc Downgrades Surgery Partners (SGRY) to Sector Weight

August 9, 2017 3:45 AM EDT

KeyBanc downgraded Surgery Partners (NASDAQ: SGRY) from Overweight to Sector Weight.

For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.

Shares of Surgery Partners closed at $19.15 yesterday.

... More

Surgery Partners, Inc. (SGRY) Misses Q2 EPS by 27c, Miss on Revenues; Offers FY17 Revenues

August 8, 2017 4:15 PM EDT

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q2 EPS of ($0.09), $0.27 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $288.4 million versus the consensus estimate of $314.22 million.

Full Year 2017 Guidance

For 2017, the Company is modifying the guidance provided on our conference call in March... More